24
Participants
Start Date
May 30, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
January 31, 2027
Standardised triple antiretroviral therapy
patients have to use Triple therapy antiretroviral drugs on their usual regimen containing an integrase inhibitor. There are many types of drugs within this group, so they are not specified.
High doses Triple therapy antiretroviral drugs
dolutegravir 50 mg/12 h, maraviroc 300 mg/12 h and lamivudine 300 mg/12 h
NOT_YET_RECRUITING
Hospital Universitario Ramón y Cajal, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
OTHER